250
Views
5
CrossRef citations to date
0
Altmetric
Research Article

A nationwide cross-sectional overview of patients with rheumatoid arthritis followed in outpatient specialty clinics in Finland

, , , , , , , , & show all
Pages 286-290 | Accepted 13 Dec 2013, Published online: 24 Mar 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Heikki Relas, Riitta Luosujärvi & Silja Kosola. (2018) Outcome of transition phase patients with juvenile idiopathic arthritis. Modern Rheumatology 28:5, pages 832-837.
Read now

Articles from other publishers (4)

Heikki Relas & Silja Kosola. (2018) Acceptable quality of life and low disease activity achievable among transition phase patients with rheumatic disease. Clinical Rheumatology 38:3, pages 785-791.
Crossref
Jaana T. Joensuu, Kalle J. Aaltonen, Pasi Aronen, Tuulikki Sokka, Kari Puolakka, Riitta Tuompo, Markku Korpela, Mikko Vasala, Kirsti Ilva, Dan Nordström & Marja Blom. (2016) Cost-effectiveness of biologic compared with conventional synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis: a Register study. Rheumatology 55:10, pages 1803-1811.
Crossref
ELENA NIKIPHOROU, TUOMAS RANNIO & TUULIKKI SOKKA. (2015) Rheumatoid Arthritis in the 21st Century: Treatment Patterns and Disease Activity States. The Journal of Rheumatology 42:9, pages 1542-1544.
Crossref
Kalle Jyri Aaltonen, Jaana Tuulikki Joensuu, Liisa Virkki, Tuulikki Sokka, Pasi Aronen, Heikki Relas, Heikki Valleala, Vappu Rantalaiho, Laura Pirilä, Kari Puolakka, Tea Uusitalo, Marja Blom, Yrjö Tapio Konttinen & Dan Nordström. (2015) Rates of Serious Infections and Malignancies Among Patients with Rheumatoid Arthritis Receiving Either Tumor Necrosis Factor Inhibitor or Rituximab Therapy. The Journal of Rheumatology 42:3, pages 372-378.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.